Skip to main content

Clinical Trial Results


Dr. Barry Borlaug and Dr. C. Michael Gibson Discuss: CAMEO-DAPA Trial: Evaluation of the Mechanism of Benefit For Dapagliflozin in Heart Failure With Preserved Ejection Fraction: An Invasive Hemodynamic Randomized Trial

Loader Loading…
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [269.60 KB]

Disclosures: TBD